MIL-1, a novel antitumor agent derived from natural product millepachine, acts as tubulin polymerization inhibitor for the treatment of hepatocellular carcinoma
机构:[a]Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China广东省中医院[b]Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China大德路总院检验科大德路总院检验科广东省中医院
Natural Science Foundation of Guangdong Province [2018A030313539], the Science Foundation of Guangdong Provincial Hospital of Chinese Medicine [YN2018QJ06], the Science Foundation of Guangdong Provincial Hospital of Chinese Medicine [YN2018ML04], the Doctoral Initiating Foundation of Guangdong Natural Sciences [2018A030310507], and the China Postdoctoral Science Foundation [2018M633038] for financial support.
基金编号:2018A030313539] the Science Foundation of Guangdong Provincial Hospital of Chinese Medicine [YN2018QJ06] the Science Foundation of Guangdong Provincial Hospital of Chinese Medicine [YN2018ML04] the Doctoral Initiating Foundation of Guangdong Natural Sciences [2018A030310507] and the China Postdoctoral Science Foundation [2018M633038
第一作者机构:[a]Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China[b]Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, Guangdong, China
通讯作者:
推荐引用方式(GB/T 7714):
Yan J,Zhuang Q,Li Z,et al.MIL-1, a novel antitumor agent derived from natural product millepachine, acts as tubulin polymerization inhibitor for the treatment of hepatocellular carcinoma[J].EUROPEAN JOURNAL OF PHARMACOLOGY.2021,898:doi:10.1016/j.ejphar.2021.173975.
APA:
Yan, J,Zhuang, Q,Li, Z,Xiong, Y,He, M...&Huang, X.(2021).MIL-1, a novel antitumor agent derived from natural product millepachine, acts as tubulin polymerization inhibitor for the treatment of hepatocellular carcinoma.EUROPEAN JOURNAL OF PHARMACOLOGY,898,
MLA:
Yan, J,et al."MIL-1, a novel antitumor agent derived from natural product millepachine, acts as tubulin polymerization inhibitor for the treatment of hepatocellular carcinoma".EUROPEAN JOURNAL OF PHARMACOLOGY 898.(2021)